The global COVID-19 pandemic has affected clinical research in many universities and research centres worldwide. How are research institutions coping with the disruption, and how will they be able to stay on track in terms of funding and targets? Prof Dr Teo Soo Hwang, Chief Scientific Officer of Cancer Research Malaysia, tells us more about how cancer research has been affected, and how she plans to keep her eye on the ball.

Produced by: Tee Shiao Eek

Presented by: Tee Shiao Eek

Download the BFM mobile app. Stay at home and stay up-to-date.

Tags:  COVID-19,  cancer,  research,  clinical trial,  oncology,  Health & Living,  The Bigger Picture,  medicine,  health,  virus,  medical funding,  medical research,  Healthcare, Pharma, Biotech,  Professional Services,  Politics, News, Current Affairs,  Health